← Back to screener

MapLight Therapeutics, Inc. MPLT

Rank #1776 · Nasdaq · $0.3B market cap
Audited by RSM US LLP, no going-concern flag in the latest filing.
Score
42.4
P/E
-4.1
P/B
-2.74
ROE
66.0%
Op. Margin
–%
Debt Ratio
-18%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -4.1x, P/B -2.74x. Ranks in the top 96% of the universe.

Profitability ★★★★★
Excellent

ROE 66.0%. Ranks in the top 6% of the universe.

Safety ★★★★★
Excellent

Debt ratio -18%. Ranks in the top 7% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2025–$-0.1B$-0.1B$-0.1B–-18

← See the full screener